Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells Lena Avinery; Danielle Regev; Hazem Khamaisi; Jacob Gopas; Jamal Mahajna;

TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA: CURRENT EVIDENCE, PREDICTORS, AND FUTURE DIRECTIONS Yunus Çatma;

Assessment of the neutrophil-to-lymphocyte ratio as a prognostic marker in patients with newly diagnosed diffuse large B-cell lymphoma: A Colombian Cohort Study Paula María Sánchez; Juan Felipe Combariza-Vallejo;